Newsfiscal.ai
Canaccord Genuity Maintains Buy Rating and Lowers Price Target for Niagen Bioscience
· Published
Article summary
Canaccord Genuity has maintained its 'Buy' rating on Niagen Bioscience while reducing its price target from $9 to $7.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…